Researchers have developed a modified CRISPR gene-editing tool with potential to silence the extra chromosome causing Down ...
A research team has discovered an enhanced CRISPR gene-editing system that could enable targeted delivery inside the human ...
A newly discovered RNA-based mechanism helps CRISPR systems maintain efficiency by preventing interference, offering insights ...
Cancer cells excel at evading detection, but subtle chemical differences set them apart from healthy cells. Now, a team of ...
The global cell therapy technologies market is set to grow from USD 4.41 billion in 2025 to USD 7.91 billion by 2030, ...
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $55.72, moving -1.83% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 0.26%. On ...
Boston researchers Stuart Orkin and Lee Roberts were honored with one of the six Breakthrough Prizes for achievements in life ...
Now, gene-edited wheat could play a key role in reducing exposure to carcinogens. Scientists at Rothamsted Research announced ...
Recent commentary has highlighted CRISPR Therapeutics’ expanding gene-editing pipeline, including cardiovascular candidates like CTX310 and CTX320 and programs in type 1 diabetes, alongside fresh Buy ...
There are plenty of reasons, though, to be bullish on the stock, not the least of which is its improved cash position. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results